Subscribe to our newsletter

Capital that Translates

Great science into

tomorrow’s Healthcare

Eckuity Capital is an investment manager providing growth and venture capital to companies across the healthcare sector. As a stage-agnostic investor, we pursue investments with strong commercial viability and a clear exit pathway.

For venture-stage investments, we look at the level of the unmet need in the market, the extent of market disruption, the depth of the scientific innovation, and the capability of the management, and importantly, the potential for commercialization, as the initial investment criteria.

For growth-stage investments we look at consistent revenue build, revenue growth and revenue retention as well as evaluate the competitive landscape (which typically is much broader than what most companies think),  as the initial investment criteria.

We bring significant value to our portfolio companies by ensuring that their technologies can be commercialized as quickly as possible. We often play an active role in assisting our companies with business leads, opening new markets, partnering with hospitals and commercial organizations, as well as opening international markets.

Investing With

Positive Impact

We focus on Impact in two ways; by investing in technology that will have significant influence on healthcare but also in companies who embody strong societal values.


Better outcomes

Better outcomes means an improvement on the current ability to treat or manage a disease or condition. Better outcomes can be achieved either by increasing efficacy or improving efficiency over a current treatment or by developing an entirely new treatment for a currently untreatable disease. Better outcomes can also be achieved by developing new treatments with lower side-effects. Side effects cause treatment drop-outs or limit who can benefit.

Wider access

Treatments are often available but with limited access to a small number of people. We look for ways to broaden access: 

Distribution – creating new access points for patients like secure online delivery, telemedicine and digital therapeutics.

Formulation enhancements can lead to greater access by making treatment simpler. A pill taken at home is more accessible than having to wait for a specialist hospital-based team for surgery.

Data and AI can be used to better understand who will benefit most from a treatment, creating greater access.

Lower cost

Cost reduction can take many forms: lower manufacturing costs to eliminating the need to refrigerate storage, to reducing the cost of giving the treatment eg a pill cost less to administer than an intravenous infusion.
The cost to develop a new drug/treatment is rising exponentially, however new technology, data and AI can speed discovery, identify the precise patients for treatment to reduce the size of clinical trials and reduce the risk of costly failures.

A culture for good

We look for management and founders that not only make impact part of their business delivery but also build impact values into their culture and business practices. We believe companies play a vital role in society as engines of creativity, innovation and economic opportunity, as well as shaping the future of sustainability.

Business with purpose

We support the Businesses with Purpose movement and encourage our partners to: Deliver value to the market, Invest in employees, Deal fairly and ethically with suppliers, Support the communities in which they work and Generate long-term value for shareholders.

Responsible development

We look for companies that are developing products that keep both environmental and human safety in mind. We ensure they contribute to practices that help conserve resources like water and energy or that actively build sustainability into their business models in the form of recycling/waste programs, carbon offsetting and ecofriendly development.

Strong societal

impact values